Company Filing History:
Years Active: 2012
Title: Anne Roulston: Innovator in Cancer Treatment
Introduction
Anne Roulston is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a focus on enhancing therapeutic methods, Roulston's work is paving the way for improved patient outcomes.
Latest Patents
Roulston holds 2 patents that focus on compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor. Her first patent relates to methods for decreasing cellular DNA repair in a target patient, decreasing cellular NAD biosynthesis, and increasing the efficiency of radiation therapy. This invention also addresses the modulation of nicotinamide phosphoribosyl transferase activity and sensitizing patients to DNA damaging therapies. The second patent focuses on methods for treating patients diagnosed with or suspected to have chronic lymphocytic leukemia (CLL), emphasizing the importance of nicotinic acid pathways in cancer treatment.
Career Highlights
Roulston is currently associated with Gemin X Pharmaceuticals Canada Inc., where she continues to advance her research in cancer therapies. Her work is characterized by a commitment to developing effective treatments that can significantly impact patient care.
Collaborations
Roulston collaborates with Pierre Beauparlant, leveraging their combined expertise to enhance the effectiveness of their research and innovations.
Conclusion
Anne Roulston's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the field. Her dedication to improving patient outcomes through scientific advancements is commendable.